Crossmark

Upregulation of TRIB2 by Wnt/β-catenin activation in BRAFV600E papillary thyroid carcinoma cells confers resistance to BRAF inhibitor vemurafenib

Published Online: 2021-04-16

Published Print: 2021-07

Authors

Wang, Nianxue

Wen, Jing

Ren, Wei

Wu, Yuting

Deng, Chaonan https://orcid.org/0000-0002-5571-9931
Funding

Funding for this research was provided by:

The National Nutural Science Foundation of China (81760141)

Guizhou Provincial Natural Science Foundation in 2016. (【2016】1122)
License Information

Text and Data Mining valid from 2021-04-16

Version of Record valid from 2021-04-16
More Information

Article History

Received: 18 November 2020

Accepted: 25 March 2021

First Online: 16 April 2021

Declarations

:

: The authors state that there are no conflicts of interest to disclose.

Document is current